Seppel T, Schlaghecke R
Abteilung Endokrinologie und Rheumatologie, Medizinische Klinik und Poliklinik, Universität Düsseldorf.
Dtsch Med Wochenschr. 1996 Apr 19;121(16):503-7; discussion 508. doi: 10.1055/s-2008-1043033.
To define in a prospective study the prevalence and manifestations of subclinical hypercortisolism in a sizeable group of patients with incidentally detected adrenal adenoma. Such tumour - although usually clinically silent - may cause discrete endocrine dysfunctions.
Between 1990 and 1994, 85 consecutive patients with incidentally discovered adrenal adenoma were investigated (54 women, 31 men; mean age 54.1 +/- 13 [24-81] years). In addition to history and clinical examination all patients had a low-dose dexamethasone suppression test (2mg) and their morning basal plasma ACTH concentration was measured. The diagnosis of subclinical hypercortisolism was made if there was inadequate suppression of cortisol after dexamethasone administration, plasma ACTH level was decreased and there were no clinical signs of Cushing's syndrome.
Five of the patients fulfilled the criteria of subclinical hypercortisolism (prevalence of 6%). One of them had oligomenorrhoea, another arterial hypertension, and three had mild histological proof of adrenal adenoma. Postoperatively the patient with oligomenorrhoea had normal menstrual cycles, while in all others with subclinical hypercortisolism excision of the tumour had no influence of their clinical state.
Subclinical hypercortisolism is rare, but is one of the most common endocrine disorders in patients with incidental adrenal adenoma. It can be diagnosed only by hormonal analysis. Once the latent cortisol excess has been eliminated, those symptoms which are due to hormonal abnormality may regress, but nonspecific signs, such as obesity or hypertension, may not necessarily improve.
在一项前瞻性研究中,确定在一组偶然发现肾上腺腺瘤的患者中亚临床皮质醇增多症的患病率及表现。此类肿瘤——尽管通常在临床上无明显症状——可能会导致轻微的内分泌功能紊乱。
1990年至1994年间,对85例连续偶然发现肾上腺腺瘤的患者进行了研究(54例女性,31例男性;平均年龄54.1±13[24 - 81]岁)。除病史和临床检查外,所有患者均进行了小剂量地塞米松抑制试验(2mg),并测定了其清晨基础血浆促肾上腺皮质激素(ACTH)浓度。若地塞米松给药后皮质醇抑制不足、血浆ACTH水平降低且无库欣综合征的临床体征,则诊断为亚临床皮质醇增多症。
5例患者符合亚临床皮质醇增多症的标准(患病率为6%)。其中1例有月经过少,另1例有动脉高血压,3例有肾上腺腺瘤的轻度组织学证据。术后,月经过少的患者月经周期恢复正常,而其他所有亚临床皮质醇增多症患者的肿瘤切除对其临床状态无影响。
亚临床皮质醇增多症较为罕见,但却是偶然发现肾上腺腺瘤患者中最常见的内分泌疾病之一。仅通过激素分析才能诊断。一旦潜在的皮质醇过量被消除,那些由激素异常引起的症状可能会消退,但肥胖或高血压等非特异性体征不一定会改善。